Geovax Labs, INC Schedule 13G passive stakes

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 387,038 shares, representing 4.99% of GeoVax Labs, Inc. common stock.

A filing reveals Ayrton Capital LLC, Alto Opportunity Master Fund, SPC, and Waqas Khatri collectively hold a 1.59% stake in GeoVax Labs, Inc. through warrants.

Reporting persons, including Intracoastal Capital LLC, have adjusted their beneficial ownership of GeoVax Labs, Inc. common stock to 4.99%, triggering a Schedule 13G filing.

Jane Street Group, LLC and its affiliates have filed an amended Schedule 13G, reporting a combined beneficial ownership of 4.3% in GeoVax Labs, Inc. common stock as of June 30, 2026.

Jane Street Group, LLC has filed a Schedule 13G reporting a 5.6% beneficial ownership stake in GeoVax Labs, Inc.

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 9.99% in GeoVax Labs, Inc. common stock as of March 31, 2026.

Intracoastal Capital LLC and associated individuals report beneficial ownership of 9.99% of GeoVax Labs' common stock as of March 31, 2026.

L1 Capital Global Opportunities Master Fund, Ltd. has reduced its beneficial ownership in GeoVax Labs, Inc. to 1.79% of common stock outstanding.

Intracoastal Capital LLC and its principals reported a 9.99% passive beneficial ownership stake in GeoVax Labs, Inc. through warrants.

Ayrton Capital LLC, along with Alto Opportunity Master Fund and Waqas Khatri, reported a 9.99% beneficial ownership stake in GeoVax Labs, primarily through warrants.

Intracoastal Capital LLC and its principals have disclosed a 9.99% beneficial ownership stake in GeoVax Labs, Inc., primarily through common stock and exercisable warrants.

Armistice Capital, LLC and Steven Boyd have reported a 9.54% beneficial ownership stake in GeoVax Labs, Inc., holding 2,675,610 shares of common stock.

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has disclosed a 9.99% beneficial ownership stake in GeoVax Labs, Inc., primarily through warrants.

L1 Capital Global Opportunities Master Fund, Ltd. has reported a passive beneficial ownership of 5.86% of GeoVax Labs, Inc.'s common stock, totaling 1,475,000 shares.

Investment firm Armistice Capital, LLC and its managing member Steven Boyd have disclosed a 9.99% beneficial ownership stake in GeoVax Labs, Inc., holding 1,612,729 shares of common stock.

Armistice Capital, LLC and its managing member Steven Boyd have disclosed a beneficial ownership of 4.99% of GeoVax Labs, Inc.'s common stock as of December 31, 2024.